[1] Rubnitz JE, Gibson Bsmith FO. Acute myeloid leukemia. Hematol Oncol Clin North Am, 2008, 24:35-63.
[2] 肖志坚. 急性白血病化疗药物所致肝损害的诊治. 中国实用内科杂志, 2011,15:910-911.
[3] Robinson SM, Wilson CH, Burt AD, et al. Chemotherapy-associated liver injury in patients with colorectal liver metastases: A systematic review and meta-analysis. Ann Surg Oncol, 2012, 19:4287-4299.
[4] 张双旗. 复方甘草酸苷注射液临床应用浅析. 中外健康文摘, 2012,12:92-95.
[5] 张之南,沈悌.血液病诊断及疗效标准(第3版).北京: 科学出版社,2007: 106-116.
[6] Pefani E, Panoskaltsis N, Mantalaris A, et al. Chemotherapy drug scheduling for the induction treatment of patients with acute myeloid leukemia. IEEE Trans Biomed Eng, 2014, 61:2049-2056.
[7] 任正刚. 化疗药物引起的肝脏损害. 肝脏, 2001,13:48-49.
[8] Rui Z, Yang J, Yan Z, et al. N -(2-Hydroxypropyl)methacrylamide Copolymer-Drug Conjugates for Combination Chemotherapy of Acute Myeloid Leukemia. Macromol Biosci, 2015, 16:121-128.
[9] 王希东. 药物性肝损伤的药理分析. 中国临床实用医学, 2010, 04:151-152.
[10] Eisen A, Dovrish Z, Hadari R, et al. Jaundice and acute liver failure as the first manifestation of acute myeloid leukemia. Isr Med Assoc J, 2008, 10:733-735.
[11] 岳兰竹, 付蓉, 阮二宝,等. 急性非淋巴细胞白血病化疗肝损伤发生率及其相关因素研究. 中国实用内科杂志, 2009,16:1009-1011.
[12] Marianecci C, Rinaldi F, Mastriota M, et al. Anti-inflammatory activity of novel ammonium glycyrrhizinate/niosomes delivery system: human and murine models. J Control Release, 2012, 164:17-25.
[13] 方燕祥, 张国强, 武新安. 甘草酸单铵对异烟肼致大鼠肝损伤的保护作用及其机制. 中国医院药学杂志, 2015, 35:1846-1850.
[14] 孙吉湘. 复方甘草酸单胺预防及治疗抗结核药物引起的肝损害疗效观察. 中华实用医药杂志, 2004,9:88-90.
[15] 陈北昌. 复方甘草酸单铵S联合血栓通对慢性乙型肝炎患者肝纤维化指标的影响. 内科, 2013, 8:360-361.
[16] 王忠成, 邵建国, 顾尔莉. 总胆红素反弹率对人工肝治疗慢加亚急性肝功能衰竭的短期预测. 中华传染病杂志, 2013, 31:678-680. |
